Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England

View ORCID ProfileT Beaney, AL Neves, A Alboksmaty, K Flott, A Fowler, JR Benger, P Aylin, S Elkin, A Darzi, View ORCID ProfileJ Clarke
doi: https://doi.org/10.1101/2021.11.24.21266818
T Beaney
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
2Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T Beaney
  • For correspondence: thomas.beaney@imperial.ac.uk
AL Neves
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Alboksmaty
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
2Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Flott
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Fowler
3NHS England and Improvement, London, SE1 6LH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JR Benger
4NHS Digital, 7-8 Wellington Place, Leeds, West Yorkshire, LS1 4AP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Aylin
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
2Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Elkin
5National Heart and Lung Institute, Imperial College London, London, SW7 2AZ United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Darzi
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Clarke
1Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, United Kingdom
6Centre for Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, SW7 2AZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Clarke
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The Covid-19 case fatality ratio varies between countries and over time but it is unclear whether variation is explained by the underlying risk in those infected. This study aims to describe the trends and risk factors for admission and mortality rates over time in England.

Methods In this retrospective cohort study, we included all adults (≥18 years) in England with a positive Covid-19 test result between 1st October 2020 and 30th April 2021. Data were linked to primary and secondary care electronic health records and death registrations. Our outcomes were i) one or more emergency hospital admissions and ii) death from any cause, within 28 days of a positive test. Multivariable multilevel logistic regression was used to model each outcome with patient risk factors and time.

Results 2,311,282 people were included in the study, of whom 164,046 (7.1%) were admitted and 53,156 (2.3%) died within 28 days. There was significant variation in the case hospitalisation and mortality risk over time, peaking in December 2020-February 2021, which remained after adjustment for individual risk factors. Older age groups, males, those resident in more deprived areas, and those with obesity had higher odds of admission and mortality. Of risk factors examined, severe mental illness and learning disability had the highest odds of admission and mortality.

Conclusions In one of the largest studies of nationally representative Covid-19 risk factors, case hospitalisation and mortality risk varied significantly over time in England during the second pandemic wave, independent of the underlying risk in those infected.

Competing Interest Statement

JC has received fees from Philips UK Limited for consultancy services outside of the submitted work. SE has received fees for an educational lecture sponsored by Astra Zeneca and is co-clinical director for the NHS England and Improvement London Respiratory Network. All other authors report no competing interests.

Funding Statement

The authors acknowledge support from NHS England and NHS Improvement, the National Institute for Health Research (NIHR) Imperial Biomedical Research Council (BRC) and the NIHR Imperial Patient Safety Translational Research Centre. JC acknowledges support from the Wellcome Trust (215938/Z/19/Z). The study funders did not play a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. In addition, researchers were independent from funders, and all authors had full access to all of the data included in this study and can take responsibility for the integrity of the data and the accuracy of the data analysis. 

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The work was conducted as part of a wider service evaluation, approved by Imperial College Healthcare Trust on December 3rd 2020. Data access was approved by the Independent Group Advising on the Release of Data (IGARD; DARS-NIC-421524-R0Y3P) on April 15th 2021.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The patient level data used in this study are not publicly available but are available to applicants meeting certain criteria through application of a Data Access Request Service (DARS) and approval from the Independent Group Advising on the Release of Data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England
T Beaney, AL Neves, A Alboksmaty, K Flott, A Fowler, JR Benger, P Aylin, S Elkin, A Darzi, J Clarke
medRxiv 2021.11.24.21266818; doi: https://doi.org/10.1101/2021.11.24.21266818
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England
T Beaney, AL Neves, A Alboksmaty, K Flott, A Fowler, JR Benger, P Aylin, S Elkin, A Darzi, J Clarke
medRxiv 2021.11.24.21266818; doi: https://doi.org/10.1101/2021.11.24.21266818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (416)
  • Anesthesia (92)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
  • Epidemiology (8589)
  • Forensic Medicine (4)
  • Gastroenterology (390)
  • Genetic and Genomic Medicine (1772)
  • Geriatric Medicine (169)
  • Health Economics (375)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (197)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10344)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (933)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (255)
  • Pediatrics (539)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1785)
  • Public and Global Health (3871)
  • Radiology and Imaging (627)
  • Rehabilitation Medicine and Physical Therapy (322)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (170)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)